Product Images Doxazosin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Doxazosin NDC 0904-5524 by Major Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

doxazosin-structure - doxazosin structure

doxazosin-structure - doxazosin structure

figure1.jpg - figure1

figure1.jpg - figure1

bottle label - image 01

bottle label - image 01

This is a medication package containing 100 tablets of Doxazosin, USP, which is dispensed only with a patient information leaflet. The package is labeled with the NDC code 0904-5522-61 along with a warning for temperature storage and an expiration date of 2120125. The package is in a unit dose format and cannot be sold separately as this is a prescription drug.*

bottle label - image 02

bottle label - image 02

This is a medication called Doxazosin Tablets, which is available only with a prescription. The package contains 100 tablets, and the NDC code is 0904552361. The text also mentions a patient information leaflet, but nothing specific can be inferred from the given information. It also includes storage instructions and some precautions for users.*

bottle label - image 03

bottle label - image 03

This is a description for a drug called Doxazosin in tablet form. The medication is available in unit doses of 100 tablets with a strength of 4 L. The NDC number is 0904-5524-61. The pharmacist is instructed to dispense the medication without the patient information leaflet. The rest of the text is not-readable.*

table3.jpg - table3

table3.jpg - table3

The text appears to be a summary of the effectiveness data in placebo-controlled trials for a medication called Doxazosin. The medication's maximum flow symptom score and rate are recorded in mL/sec, with baseline change data compared to a placebo. The summary also includes information about three different studies that were conducted, noting the questionnaire used and changes made to the endpoint. However, there seems to be some missing information or errors in the text, making it difficult to fully understand the results.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.